Blog

The world of healthcare is constantly evolving, and recent years have witnessed a significant shift from traditional clinical lab assays to at-home and point-of-care testing. A need for more patient-centric, accessible, and efficient healthcare drives this transformation. Mariely Medina-Rivera, a Research Scientist at iFyber, explains the steps involved in advancing Point of Care (POC) and…

Choosing between immunoassays and molecular assays depends on what you need to detect, the specimen available, the required sensitivity and specificity, the intended use of the assay, and practical considerations such as development cost and turnaround time.  Immunoassays and molecular assays are two distinct diagnostic approaches used in healthcare and research. Immunoassays are widely used in clinical…

Osteoinductive & osteoconductive biomaterials now play a crucial role in the treatment of traumatic, developmental, and pathological bone defects. Their purpose is to substitute or repair damaged bone. These biomaterials can be permanent or temporary and come in various forms, both natural (e.g., allografts and xenografts) and synthetic (e.g., alloplasts, metals, ceramics, polymers, and composites).…

Determining cytotoxicity is a critical step in assessing the biocompatibility of medical devices, biomaterials, and drug screening. There are a wide variety of methods available to researchers; however, too often cell-based assay results indicating poor cell health without greater context slow down or halt progress on the development of a medical device. Technology is constantly…